| Product Code: ETC6887854 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Cyprus continued to receive significant antibody import shipments from top exporting countries including Belgium, Slovenia, Greece, Germany, and the Netherlands. Despite a decrease in the Herfindahl-Hirschman Index (HHI) from very high concentration in 2023 to high concentration in 2024, the market remained dominated by key players. The compound annual growth rate (CAGR) for the period 2020-2024 was -5.62%, indicating a decline in overall market size. However, there was a notable growth rate of 23.95% from 2023 to 2024, suggesting a potential resurgence in demand for antibodies in Cyprus.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Antibodies Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Antibodies Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Antibodies Market - Industry Life Cycle |
3.4 Cyprus Antibodies Market - Porter's Five Forces |
3.5 Cyprus Antibodies Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Cyprus Antibodies Market Revenues & Volume Share, By Antibodes Type, 2021 & 2031F |
3.7 Cyprus Antibodies Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Cyprus Antibodies Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Cyprus Antibodies Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Cyprus Antibodies Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Cyprus Antibodies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Antibodies Market Trends |
6 Cyprus Antibodies Market, By Types |
6.1 Cyprus Antibodies Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Antibodies Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Cyprus Antibodies Market Revenues & Volume, By Primary, 2021- 2031F |
6.1.4 Cyprus Antibodies Market Revenues & Volume, By Secondary, 2021- 2031F |
6.2 Cyprus Antibodies Market, By Antibodes Type |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Antibodies Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.2.3 Cyprus Antibodies Market Revenues & Volume, By Polyclonal Antibodies, 2021- 2031F |
6.3 Cyprus Antibodies Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Antibodies Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.3.3 Cyprus Antibodies Market Revenues & Volume, By Immunofluorescence, 2021- 2031F |
6.3.4 Cyprus Antibodies Market Revenues & Volume, By Western Blotting, 2021- 2031F |
6.3.5 Cyprus Antibodies Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.6 Cyprus Antibodies Market Revenues & Volume, By Immunoprecipitation, 2021- 2031F |
6.3.7 Cyprus Antibodies Market Revenues & Volume, By ELISA, 2021- 2031F |
6.4 Cyprus Antibodies Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Antibodies Market Revenues & Volume, By Mouse, 2021- 2031F |
6.4.3 Cyprus Antibodies Market Revenues & Volume, By Rabbit, 2021- 2031F |
6.4.4 Cyprus Antibodies Market Revenues & Volume, By Goat, 2021- 2031F |
6.4.5 Cyprus Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Cyprus Antibodies Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Cyprus Antibodies Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.5.3 Cyprus Antibodies Market Revenues & Volume, By Immunology, 2021- 2031F |
6.5.4 Cyprus Antibodies Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.5 Cyprus Antibodies Market Revenues & Volume, By Stem Cells, 2021- 2031F |
6.5.6 Cyprus Antibodies Market Revenues & Volume, By Neurobiology, 2021- 2031F |
6.5.7 Cyprus Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Cyprus Antibodies Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 Cyprus Antibodies Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.6.3 Cyprus Antibodies Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.6.4 Cyprus Antibodies Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
7 Cyprus Antibodies Market Import-Export Trade Statistics |
7.1 Cyprus Antibodies Market Export to Major Countries |
7.2 Cyprus Antibodies Market Imports from Major Countries |
8 Cyprus Antibodies Market Key Performance Indicators |
9 Cyprus Antibodies Market - Opportunity Assessment |
9.1 Cyprus Antibodies Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Cyprus Antibodies Market Opportunity Assessment, By Antibodes Type, 2021 & 2031F |
9.3 Cyprus Antibodies Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Cyprus Antibodies Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Cyprus Antibodies Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 Cyprus Antibodies Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Cyprus Antibodies Market - Competitive Landscape |
10.1 Cyprus Antibodies Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Antibodies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |